Subtype-selective induction of apoptosis in translocation-related sarcoma cells induced by PUMA and BIM upon treatment with pan-PI3K inhibitors
Isoyama, Sho, Tamaki, Naomi, Noguchi, Yutaka, Okamura, Mutsumi, Yoshimatsu, Yuki, Kondo, Tadashi, Suzuki, Takeshi, Yaguchi, Shin-ichi, Dan, Shingo
Published in Cell death & disease (27.02.2023)
Published in Cell death & disease (27.02.2023)
Get full text
Journal Article
M-COPA, a Golgi Disruptor, Inhibits Cell Surface Expression of MET Protein and Exhibits Antitumor Activity against MET-Addicted Gastric Cancers
Ohashi, Yoshimi, Okamura, Mutsumi, Hirosawa, Asaka, Tamaki, Naomi, Akatsuka, Akinobu, Wu, Kuo-Ming, Choi, Hyeong-Wook, Yoshimatsu, Kentaro, Shiina, Isamu, Yamori, Takao, Dan, Shingo
Published in Cancer research (Chicago, Ill.) (01.07.2016)
Published in Cancer research (Chicago, Ill.) (01.07.2016)
Get full text
Journal Article
Basal expression of insulin‐like growth factor 1 receptor determines intrinsic resistance of cancer cells to a phosphatidylinositol 3‐kinase inhibitor ZSTK474
Isoyama, Sho, Kajiwara, Gensei, Tamaki, Naomi, Okamura, Mutsumi, Yoshimi, Hisashi, Nakamura, Naoki, Kawamura, Kento, Nishimura, Yumiko, Namatame, Nachi, Yamori, Takao, Dan, Shingo
Published in Cancer science (01.02.2015)
Published in Cancer science (01.02.2015)
Get full text
Journal Article
Antitumor profile of the PI3K inhibitor ZSTK474 in human sarcoma cell lines
Namatame, Nachi, Tamaki, Naomi, Yoshizawa, Yuya, Okamura, Mutsumi, Nishimura, Yumiko, Yamazaki, Kanami, Tanaka, Miwa, Nakamura, Takuro, Semba, Kentaro, Yamori, Takao, Yaguchi, Shin-Ichi, Dan, Shingo
Published in Oncotarget (12.10.2018)
Published in Oncotarget (12.10.2018)
Get full text
Journal Article
Abstract 3909: Potential antitumor effect of a pan-PI3K inhibitor ZSTK474 on human sarcoma cell lines
Dan, Shingo, Tamaki, Naomi, Namatame, Nachi, Yoshizawa, Yuya, Okamura, Mutsumi, Nishimura, Yumiko, Yamazaki, Kanami, Yaguchi, Shin-ichi
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article
Recombinant human lactoferrin-Fc fusion with an improved plasma half-life
Shiga, Yuki, Oshima, Yuta, Kojima, Yoshinori, Sugimoto, Akinori, Tamaki, Naomi, Murata, Daisuke, Takeuchi, Takashi, Sato, Atsushi
Published in European journal of pharmaceutical sciences (25.01.2015)
Published in European journal of pharmaceutical sciences (25.01.2015)
Get full text
Journal Article
Abstract A43: Basal expression of insulin-like growth factor 1 receptor determines intrinsic resistance of cancer cells to a PI3K inhibitor ZSTK474
Isoyama, Sho, Kajiwara, Gensei, Tamaki, Naomi, Mutsumi, Okamura, Yoshimi, Hisashi, Nakamura, Naoki, Nishimura, Yumiko, Yamori, Takao, Dan, Shingo
Published in Molecular cancer therapeutics (01.07.2015)
Published in Molecular cancer therapeutics (01.07.2015)
Get full text
Journal Article
Abstract 4450: Identification of IGF1R as a responsible factor and a therapeutic target for overcoming acquired and intrinsic resistance to PI3K inhibitors
Dan, Shingo, Isoyama, Sho, Nishimura, Yumiko, Nakamura, Naoki, Kajiwara, Gensei, Tamaki, Naomi, Okamura, Mutsumi, Yamori, Takao
Published in Cancer research (Chicago, Ill.) (15.04.2013)
Published in Cancer research (Chicago, Ill.) (15.04.2013)
Get full text
Journal Article
Abstract C96: Development of combination therapy with an IGF1R inhibitor and a PI3K inhibitor ZSTK474 in cancer cells exhibiting the intrinsic resistance to PI3K inhibitors
Isoyama, Sho, Kajiwara, Gensei, Tamaki, Naomi, Yoshimi, Hisashi, Nakamura, Naoki, Okamura, Mutsumi, Nishimura, Yumiko, Yamori, Takao, Dan, Shingo
Published in Molecular cancer therapeutics (01.11.2013)
Published in Molecular cancer therapeutics (01.11.2013)
Get full text
Journal Article